Full Press Release Details
Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY
Image of O2TODAY's mask prototype which will be available for limited pre-orders starting
LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or
the "Company"), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced
today it has moved into the next phase of its relationship with O2TODAY and sold the first shipment of FleX SN-AP antipathogenic
silicon nitride powder to O2TODAY for integration into a proprietary line of masks and filters.
announced on its website today that it is taking limited pre-orders for masks and mask filters integrated with SINTX's antipathogenic
powder," said Dr. Sonny Bal, President and CEO at SINTX Technologies. "We share the excitement at this development, and we've
appreciated the opportunity to collaborate on the development of O2TODAY's products over the past year."
is the supplier of FleX SN-AP antipathogenic silicon nitride powder to O2TODAY. The powder is used to make O2TODAY's face masks
and mask filters which were developed during a collaboration entered by the two companies in the midst of the 2020 COVID-19 pandemic.
That collaboration has led to several milestones including a 2-year Technology License Agreement with a fee for the exclusive use of
SINTX's technology in face masks and mask filters, a commercial agreement on silicon nitride sales, and royalties from product
continues to work with other partners to develop products with its FleX SN-AP powder. SINTX's FleX SN-AP can rapidly inactivate
a wide range of bacteria, molds, and viruses, including SARS-CoV-2, Influenza A, and H1N1. FleX SN-AP can be incorporated into many consumer
products and touch surfaces, making them resistant to disease-causing microbes. The SINTX R&D team has the knowledge and expertise
to create niche applications with FleX SN-AP technology to enhance your company's products.
masks and filters with silicon nitride are expected to become available for limited pre-orders starting on July 6, 2021. For more information
please visit https://o2today.com/products/sinpro
direct inquiries to info@o2today.com.
SINTX Technologies, Inc.
Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The
core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners.
The Company presently manufactures silicon nitride powders and components in its FDA registered, ISO 13485:2016 certified, and ASD9100D
certified manufacturing facility.
more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com.
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA)
that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other
things: that O2TODAY will be able to manufacture a face mask incorporating FleX SN-AP antipathogenic silicon nitride powder and that
it will be able to manufacture such face marks in commercial quantities; demand for O2TODAY'S face mask is uncertain and it may
not be able to manufacture at a cost that is competitive with other face masks; no assurance can be given the O2TODAY mask and filters
will become available for limited pre-orders starting July 6, 2021; volatility in the price of SINTX's common stock; the uncertainties
inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our
products once commercialized; SINTX's ability to raise funding and other competitive developments. Readers are cautioned not to
place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's
current estimates, projections, expectations and beliefs. There can be no assurance that any of the anticipated results will occur on
a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX's Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 22, 2021, and in SINTX's other
filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly
revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.
Inquiries for SINTX:
Inquiries for SINTX: